Private capital keeps raiding the small-cap bench, and the premiums are getting hard to ignore

by Maya Okafor · August 12, 2026

Deals & Listings Reporter, The SmallCap Signal

The most consistent bid for small- and mid-cap US equities this summer has not come from index funds or retail flows. It has come from private capital, and it keeps arriving at premiums that public shareholders have not been able to generate on their own.

The latest example is Bowman Consulting Group. The engineering services firm said on August 10 that it agreed to be acquired by Bernhard Capital Partners for $43.00 a share in cash, valuing the company at roughly $1.0 billion including debt, according to the company's announcement. The price represents a 58% premium to Bowman's August 7 closing price of $27.23 and a 57% premium to its 30-day volume-weighted average price.

Bowman is precisely the kind of business that tends to get overlooked on public markets: more than 2,500 employees across roughly 100 US offices, delivering infrastructure and engineering work that is steady, contracted and unglamorous. The agreement includes a 35-day go-shop period running through September 13, and holders of about 15.3% of voting power have committed to support the deal. BofA Securities advised the company.

A week earlier, KKR agreed to acquire Integer Holdings, a medical device contract developer and manufacturer, in a transaction the company valued at approximately $5.7 billion. Integer said the $127-a-share price marked roughly a 51.8% premium to its April 29 close and a 28.8% premium to its 30-day VWAP as of July 31. The business, which operates through brands including Greatbatch Medical and Lake Region Medical and employs around 11,000 people, expects the deal to close by the end of the year.

The pattern extends further down the market-cap ladder. AstroNova, a specialty printing and data acquisition company, agreed in June to be taken private by Arcline Investment Management at $29.00 a share. The company's merger proxy shows the stock closed at $16.69 on June 16, the day of the announcement, and puts aggregate merger consideration at roughly $227.4 million across 7,841,201 shares. Shareholders vote on August 25, with a termination fee of $9,648,000 running in each direction.

Three deals do not make a trend on their own, but the surrounding market data suggests they are not anomalies either. White & Case reported that the value of US public deals above $100 million rose 44% year over year in the first half of 2026 while volume grew just 16%, with megadeal value above $5 billion up 149%. Antitrust filings tracked the same direction, with Hart-Scott-Rodino notifications up 14%. The firm also counted 62 global activist campaigns in the period, roughly two-thirds of them in the US — pressure that frequently precedes a sale process.

The valuation gap helps explain the arithmetic. EBC Financial Group noted that the Russell 2000 was trading at a forward multiple of about 18 times at the end of 2025 against roughly 26 times for the S&P 500. When a sponsor can underwrite a business at a small-cap multiple and finance it against cash flows that look nothing like a speculative growth story, a 50% premium to an unloved public price is not necessarily a generous offer.

For investors in the size band, the consequence is a shrinking pool of listed names in exactly the categories — engineering services, contract manufacturing, industrial instrumentation — that anchor the quality end of the small-cap universe. Each take-private removes a company that the public market had already discounted, and the replacement supply from new listings has not obviously kept pace.